Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningitis, Bacterial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002076
What this trial is testing

Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Testing effectiveness (Phase 2)UnknownNCT00752882
What this trial is testing

Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration

Who this might be right for
Pseudomonas Aeruginosa Meningitis
University Hospital, Clermont-Ferrand 24
Large-scale testing (Phase 3)Study completedNCT00539032
What this trial is testing

Immunology and Safety of Menactra® in Children in Saudi Arabia

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 238
Large-scale testing (Phase 3)Study completedNCT03077438
What this trial is testing

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,000
Large-scale testing (Phase 3)Study completedNCT02173704
What this trial is testing

Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.

Who this might be right for
Meningococcal DiseaseInfections, Meningococcal
GlaxoSmithKline 225
Not applicableStudy completedNCT00002075
What this trial is testing

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Not applicableNot Yet RecruitingNCT07826351
What this trial is testing

Exploring the Combination of Intracalvariosseous and Intravenous Antibiotics for Moderate to Severe Bacterial Meningitis

Who this might be right for
Blood-Brain BarrierBacterial Meningitis
yilong Wang 9
Not applicableLooking for participantsNCT07027475
What this trial is testing

Acute Treatment and Long-term Assessment of Adult Infectious Meningitis

Who this might be right for
Viral MeningitisBacterial MeningitisFungal Meningitis+1 more
Hospital Israelita Albert Einstein 624
Testing effectiveness (Phase 2)UnknownNCT06337071
What this trial is testing

The ACYW135 Meningococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT00474526
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Who this might be right for
Meningitis, Meningococcal
Novartis Vaccines 4,545
Not applicableStudy completedNCT00000708
What this trial is testing

Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT03433482
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,707
Large-scale testing (Phase 3)Looking for participantsNCT07505836
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 1,040
Not applicableStudy completedNCT02434172
What this trial is testing

CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa

Who this might be right for
Cryptococcal Meningitis
University of Zimbabwe 1,333
Large-scale testing (Phase 3)Looking for participantsNCT03945448
What this trial is testing

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

Who this might be right for
Cryptococcal Meningitis
Makerere University 356
Not applicableUnknownNCT03499652
What this trial is testing

Neonatal Bacterial Meningitis Cohort

Who this might be right for
Bacterial MeningitisNeonatal Infection
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 10,000
Testing effectiveness (Phase 2)Study completedNCT00297817
What this trial is testing

Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 203
Testing effectiveness (Phase 2)Study completedNCT00772070
What this trial is testing

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
MeningitisMeningococcemiaNeisseria Meningitidis
Sanofi Pasteur, a Sanofi Company 173
Large-scale testing (Phase 3)Study completedNCT01725217
What this trial is testing

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia

Who this might be right for
Meningococcal Disease
Novartis Vaccines 198
Testing effectiveness (Phase 2)Ended earlyNCT00324025
What this trial is testing

Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS

Who this might be right for
Cryptococcal Meningitis
Novartis Pharmaceuticals 3
Next Page